Serum HE4 Detects Ovarian Cancer Recurrence Earlier Than CA 125: Indian Study

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 5

Abstract

ABSTRACT Introduction: Recurrence is a frequent phenomenon of the natural history of epithelial Ovarian Cancer (OC). Early detection of recurrence is important. Clinical examination combined with Carbohydrate Antigen 125 (CA125) and imaging are used for the follow-up of these patients. Human Epididymis Protein 4 (HE4) is a recent marker which is found to have elevated in OC. Aim: To study the role of HE4 in detection of OC recurrence. Materials and Methods: This prospective study was conducted at Department of Surgical Oncology, King George’s Medical University, Lucknow, Uttar Pradesh, India. Patients were enrolled from January 2014 to January 2016 after informed written consent. Total 65 patients of carcinoma ovary were prospectively followed up after completion of their primary treatment. 19 patients had clinical evidence of recurrence as detected by radiological imaging and subsequently proved by pathological examination. Timing and levels of rise in tumour marker were studied and correlated with timing of clinical evidence of disease. Results: HE4 and CA125 detected recurrence in 19 (100%) and 14 (73.7%) patients respectively. Among these 5 (26.3%) recurrence were detected by HE4 alone. In 10 (52.6%) patients, simultaneous rise in both of these markers were noticed and in 4 (21.1%) patients HE4 started rising before CA125 with a lead time of 3.25 months. CA125 was found to be in normal range in all mucinous carcinoma and two out of 16 serous carcinoma. Conclusion: HE4 is a potential useful serum marker to detect OC recurrence timely and better as compared to traditional utilised CA125. Future studies based on recurrence detection by HE4 may provide evidence on its role on survival.

Authors and Affiliations

Naseem Akhtar, Shiv Rajan, Vijay Kumar, Sonali Sharma, Sumaira Qayoom, Sourabh Mukharjee, Wahid Ali, Arun Chaturvedi

Keywords

Related Articles

Efficacy of Structured Yoga Intervention for Sleep, Gastrointestinal and Behaviour Problems of ASD Children: An Exploratory Study

Introduction: Autism Spectrum Disorder (ASD) is a neuro developmental disorder which appears at early childhood age between 18 and 36 months. Apart from behaviour problems ASD children also suffer from sleep and Gastroin...

Comparison of Efficacy of Low Dose (25 mg) with High Dose Diclofenac (50 mg) in Management of Postoperative Pain after Periodontal Flap Surgery: A Randomised Clinical Trial

ABSTRACT Introduction: The perception of pain is highly subjective and varies substantially among individuals. Diclofenac is powerful NSAID and is associated with adverse effect, like gastric irritability. Aim: To compar...

A Comparative Analysis of Two Different Dose Fractionation Regimens of High Dose Rate Intracavitary Brachytherapy in Treatment of Carcinoma of Uterine Cervix: A Prospective Randomized Study

Introduction: High Dose Rate (HDR) intracavitary brachytherapy is an integral component in treatment of carcinoma uterine cervix. There is no consensus about optimal fractionation in HDR brachytherapy. Aim: To assess the...

Effect of 5% Chlorine Dioxide Irrigant on Micro Push Out Bond Strength of Resin Sealer to Radicular Dentin: An In Vitro Study

Introduction: Chlorine dioxide (ClO2 ) has been recently investigated as a possible root canal irrigant due to its broad spectrum of antimicrobial action, tissue dissolution and smear layer removal properties. Literature...

Malignant Peripheral Nerve Sheath Tumour of the Ovary

ABSTRACT Malignant Peripheral Nerve Sheath Tumour (MPNST) of the ovary is a rare disease, and we hereby describe this entity in a 51-year-old lady who presented with an ovarian mass and disseminated peritoneal disease. S...

Download PDF file
  • EP ID EP524338
  • DOI 10.7860/JCDR/2018/35482.11542
  • Views 72
  • Downloads 0

How To Cite

Naseem Akhtar, Shiv Rajan, Vijay Kumar, Sonali Sharma, Sumaira Qayoom, Sourabh Mukharjee, Wahid Ali, Arun Chaturvedi (2018). Serum HE4 Detects Ovarian Cancer Recurrence Earlier Than CA 125: Indian Study. Journal of Clinical and Diagnostic Research, 12(5), 1-3. https://europub.co.uk/articles/-A-524338